Durability and clinical impact of tricuspid valve procedures in patients receiving a continuous-flow left ventricular assist device Jiho Han, BS, Koji.

Slides:

Advertisements

Similar presentations

Concomitant Aortic Valve Repair in Patients Undergoing Continuous-flow Left Ventricular Assist Device Placement: A 10-year Experience and Clinical Implications.

Advertisements

Pre-operative mortality risk assessment in patients with continuous-flow left ventricular assist devices: Application of the HeartMate II risk score

Aortic valve replacement in low-flow, low-gradient aortic stenosis: Left ventricular ejection fraction matters Victor Dayan, MD, PhD, Philippe Pibarot,

A hybrid configuration of a left ventricular assist device and venovenous extracorporeal membrane oxygenation Louis Samuels, MD, Eric Gnall, DO, Elena.

Long-term mechanical circulatory support: A new disease state?

The American Association for Thoracic Surgery 2016 Ethics Forum: Cost-effectiveness and the ethics of left ventricular assist device therapy John W.C.

Shinichi Fukuhara, MD, Koji Takeda, MD, PhD, Paul A

The RECOVER I: A multicenter prospective study of Impella 5

Association of device surface and biomaterials with immunologic sensitization after mechanical support Isaac George, MD, Patrick Colley, BS, Mark J.

Mild-to-moderate functional tricuspid regurgitation in patients undergoing mitral valve surgery Sun Kyun Ro, MD, Joon Bum Kim, MD, Sung Ho Jung, MD,

Pulmonary hypertension in valve disease: A beast of the past?

Impact of the Maze operation on the progression of mild functional tricuspid regurgitation Hyung Gon Je, MD, Hyun Song, MD, Sung Ho Jung, MD, Suk Jung.

Elucidating the intricate mechanisms of gastrointestinal bleeding in a continuous-flow left ventricular assist device will lead to future therapeutic.

Form ever follows function

Victor van Berkel, MD, PhD

Tricuspid annuloplasty concomitant with mitral valve surgery: Effects on right ventricular remodeling Philippe B. Bertrand, MD, MSc, Gille Koppers, MSc,

Detachment of the tricuspid valve for ventricular septal defect closure in infants younger than 3 months Ji Hyun Bang, MD, Chun Soo Park, MD, PhD, Jeong-Jun.

Outcomes of contemporary mechanical circulatory support device configurations in patients with severe biventricular failure Allison P. Levin, BA, MSc,

Hassane Abdallah, MD, Alaae Boutayeb, MD, Gebrine El Khoury, PhD

Bicuspid aortic valve aortopathy: One size fits all?

Intra-aortic balloon pump therapy negatively affects flow through a continuous-flow left ventricular assist device Dipanjan Banerjee, MD, MS, Chun Choi,

Risk-corrected impact of mechanical versus bioprosthetic valves on long-term mortality after aortic valve replacement Ole Lund, MD, PhD, Martin Bland,

The lord of the rings Antonio Miceli, MD, PhD

Expanding left ventricular assist device use to patients with disabilities: The role of assistive technology Juan A. Crestanello, MD The Journal of.

Natural history of coexistent tricuspid regurgitation in patients with degenerative mitral valve disease: Implications for future guidelines Andrew B.

Does the degree of preoperative mitral regurgitation predict survival or the need for mitral valve repair or replacement in patients with anomalous origin.

Intra-aortic balloon pumps and continuous flow left ventricular assist devices: Don't let balloon pumps overstay their welcome Kevin G. Soucy, PhD, Steven.

Long-term outcome of patients on continuous-flow left ventricular assist device support Koji Takeda, MD, PhD, Hiroo Takayama, MD, PhD, Bindu Kalesan,

Support Your Specialty

Left ventricular assist device therapy in a patient with hearing and speech disabilities Sotirios Spiliopoulos, MD, PhD, Vera Hergesell, MD, Otto Dapunt,

Abdul Rahman Dakkak, MD, Angelo M. Dell'Aquila, MD, Juergen R

Innovation and science: The future of valve design

The role of cognitive dissonance in the management of functional tricuspid regurgitation at the time of degenerative mitral valve repair Rakesh M. Suri,

Ranjit John, MD, Yoshifumi Naka, MD, Soon J

Right ventricular failure after cardiac surgery: Why can't right ventricular assist device support fix the problem? Francis D. Pagani, MD, PhD The Journal.

Successful combined procedure of HeartMate II left ventricular assist device implantation and minimally invasive transapical aortic valve replacement

Durability of left ventricular assist devices: Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) 2006 to 2011 William L.

William L. Holman, MD, James K. Kirklin, MD, David C

Tricuspid regurgitation or Ebsteinoid dysplasia of the tricuspid valve in congenitally corrected transposition: Is valvuloplasty necessary at anatomic.

Posttransplant Outcomes Among Septuagenarians Bridged to Transplantation With Continuous-Flow Left Ventricular Assist Devices Shinichi Fukuhara, MD,

Chronic obstructive pulmonary disease severity influences outcomes after off-pump coronary artery bypass Benjamin Medalion, MD, Michael G. Katz, MD,

Tricuspid annuloplasty prevents right ventricular dilatation and progression of tricuspid regurgitation in patients with tricuspid annular dilatation.

Minimally invasive tricuspid valve surgery in patients at high risk

Marc Licker, MD, John Diaper, RA

The Ross procedure: Time to reevaluate the guidelines

Commentary: Ongoing advancements in the understanding of tricuspid valve dynamics and functional geometry Daniel J.P. Burns, MD, MPhil The Journal of.

Passing the torch The Journal of Thoracic and Cardiovascular Surgery

Sutureless valve implantation: Every detail counts

T. Brett Reece, MD The Journal of Thoracic and Cardiovascular Surgery

Left ventricular assist device implantation after acute anterior wall myocardial infarction and cardiogenic shock: A two-center study Nicholas C. Dang,

Insertion of a left ventricular assist device in patients without thorough transplant evaluations: a worthwhile risk? Mathew Williams, MD, Jennifer Casher,

Quality of life after aortic valve surgery: Replacement versus reconstruction Diana Aicher, MD, Annika Holz, Susanne Feldner, MD, Volker Köllner, MD,

The Journal of Thoracic and Cardiovascular Surgery

Discussion The Journal of Thoracic and Cardiovascular Surgery

Severe tricuspid or mitral regurgitation in inoperable patients with aortic stenosis. Can we leave them alone? Juan A. Crestanello, MD The Journal of.

The future of cardiac surgery training: A survival guide

Ventricular assistant in restrictive cardiomyopathy: Making the right connection Robert D.B. Jaquiss, MD The Journal of Thoracic and Cardiovascular Surgery

Postcardiac transplant survival in the current era in patients receiving continuous-flow left ventricular assist devices Forum Kamdar, MD, Ranjit John,

Surgical treatment of tricuspid valve insufficiency promotes early reverse remodeling in patients with axial-flow left ventricular assist devices Simon.

Tricuspid annulus diameter does not predict the development of tricuspid regurgitation after mitral valve repair for mitral regurgitation due to degenerative.

Seeing is believing: A call for routine early postoperative hemodynamic transesophageal echocardiography monitoring after left ventricular assist device.

Optimal timing for heart transplantation in patients bridged with left ventricular assist devices: Is timing of the essence? Chase R. Brown, MD, Fabliha.

Should heart transplantation be considered as a treatment option for patients aged 70 years and older? Jeffrey A Morgan, MD, Ranjit John, MD, Donna M.

Daisuke Yoshioka, MD, Hiroo Takayama, MD, Arthur R. Garan, MD, Veli K

Preoperative PFTs: The answer is blowing in the wind

Chordal replacement with polytetrafluoroethylene sutures for mitral valve repair: A 25- year experience Tirone E. David, MD, Susan Armstrong, MSc, Joan.

Gastrointestinal bleeding after left ventricular assist device implantation: It is all about the platelets Juan A. Crestanello, MD The Journal of Thoracic.

Did you like Terminator 3 better than Terminator 2

How do we follow up our patients

Lessons learned from Melody valve retrieved at transplantation

Presentation transcript:

Durability and clinical impact of tricuspid valve procedures in patients receiving a continuous-flow left ventricular assist device Jiho Han, BS, Koji Takeda, MD, PhD, Hiroo Takayama, MD, PhD, Paul A. Kurlansky, MD, Christine M. Mauro, PhD, Paolo C. Colombo, MD, Melana Yuzefpolskaya, MD, Shinichi Fukuhara, MD, Lauren K. Truby, MD, Veli K. Topkara, MD, Arthur R. Garan, MD, Donna M. Mancini, MD, Yoshifumi Naka, MD, PhD The Journal of Thoracic and Cardiovascular Surgery Volume 151, Issue 2, Pages 520-527.e1 (February 2016) DOI: 10.1016/j.jtcvs.2015.09.082 Copyright © 2016 Terms and Conditions

Figure 1 Overall 2-year survival in group A versus B. Group A: TVP. Group B: no TVP. LVAD, Left ventricular assist device; TVP, tricuspid valve procedure. The Journal of Thoracic and Cardiovascular Surgery 2016 151, 520-527.e1DOI: (10.1016/j.jtcvs.2015.09.082) Copyright © 2016 Terms and Conditions

Figure 2 Six-month survival of subgroups based on TVP and degree of preoperative TR. A, Moderate TR with TVP. B, No significant TR and no TVP. C, Moderate TR and no TVP. D, Moderate-severe TR with TVP. TR, Tricuspid regurgitation; TVP, tricuspid valve procedure; LVAD, left ventricular assist device. The Journal of Thoracic and Cardiovascular Surgery 2016 151, 520-527.e1DOI: (10.1016/j.jtcvs.2015.09.082) Copyright © 2016 Terms and Conditions

Figure 3 Two-year mean cumulative overall readmissions in group A versus B. Group A: TVP. Group B: no TVP. TVP, Tricuspid valve procedure. The Journal of Thoracic and Cardiovascular Surgery 2016 151, 520-527.e1DOI: (10.1016/j.jtcvs.2015.09.082) Copyright © 2016 Terms and Conditions

Figure 4 Two-year mean cumulative readmissions due to RHF in group A versus B. Group A: TVP. Group B: no TVP. TVP, Tricuspid valve procedure. The Journal of Thoracic and Cardiovascular Surgery 2016 151, 520-527.e1DOI: (10.1016/j.jtcvs.2015.09.082) Copyright © 2016 Terms and Conditions

Figure 5 A, Frequencies of TR severity over time in group A (TVP). B, Frequencies of TR severity over time in group B (no TVP). LVAD, Left ventricular assist device. The Journal of Thoracic and Cardiovascular Surgery 2016 151, 520-527.e1DOI: (10.1016/j.jtcvs.2015.09.082) Copyright © 2016 Terms and Conditions

Six-month survival of subgroups based on TVP and degree of preoperative TR. The Journal of Thoracic and Cardiovascular Surgery 2016 151, 520-527.e1DOI: (10.1016/j.jtcvs.2015.09.082) Copyright © 2016 Terms and Conditions